Director Market Access EuropeCSL Behring, Milan, ItalyMilan, Lombardia, Italy
PB0490 - Real-world outcomes of prophylaxis with extended half-life factor IX products for hemophilia B: a pooled analysis of medical chart data from Germany and Italy
Monday, June 24, 202413:45 – 14:45 ICT